<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02166606</url>
  </required_header>
  <id_info>
    <org_study_id>GENTLE-1013</org_study_id>
    <nct_id>NCT02166606</nct_id>
  </id_info>
  <brief_title>INGEVITY™ Observational Trial</brief_title>
  <acronym>GENTLE</acronym>
  <official_title>INGEVITY™ Observational Trial: Assessment of Routine Experience and Magnet Resonance Imaging (MRI) Usage With a New Lead for Bradycardia Pacing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this registry are to

        1. Collect clinical data on Boston Scientific's ImageReady MR Conditional Pacing Systems
           involving the INGEVITY lead based on observations / events

        2. Gather data on actual number of MRI scans performed in the patient cohort implanted with
           an ImageReady system including information about scanned body parts.

        3. Collect physician feedback on lead handling with the INGEVITY lead

      in a real-life, market-released standard of care environment using devices on intended
      purpose and which are authorized to bear the CE (Communauté Européenne) marking / are
      approved for use in the applicable area of participating centers. No additional invasive or
      other burdensome examinations are to be carried out other than the ones conducted by the
      centers per their general standard of care.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Leads Free From Complication</measure>
    <time_frame>91 calendar days post-implant</time_frame>
    <description>Lead-related complication-free rate from lead implant through the three month follow-up, based on complications that are related to the INGEVITY Lead.</description>
  </primary_outcome>
  <other_outcome>
    <measure>MRI Procedures Through 12 Months Post-Implant</measure>
    <time_frame>365 calendar days post implant</time_frame>
    <description>The percentage of subjects who underwent an MRI scan through 12 months post-implant.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1184</enrollment>
  <condition>Bradycardia</condition>
  <arm_group>
    <arm_group_label>Pacemaker/Lead implant</arm_group_label>
    <description>All enrolled subjects will receive an ImageReady Magnet Resonant (MR) Conditional Pacing System and the treatment assignment will be based on an &quot;all-comers&quot; consecutive basis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ImageReady MR Conditional Pacing System Implant</intervention_name>
    <description>Implant according to standard-of-care. No study-specific interventions in that registry.</description>
    <arm_group_label>Pacemaker/Lead implant</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The subjects will be coming from the general patient population of the participating
        centers who are indicated for implantation of a BSC (Boston Scientific) ImageReady Pacing
        System (pulse generator [PG] &amp; leads) and who are fulfilling all inclusion criteria and
        none of the exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is willing and capable of providing informed consent and to give approval to
             collect / store / process personal health information by the sponsor

          -  Subject is scheduled for, or implanted with, a clinically indicated BSC ImageReady
             system according to current and locally applicable implant guidelines such as
             published by European Society of Cardiology (ESC) / American Heart Association (AHA) /
             American College of Cardiology (ACC) / Hearth Rhythm Society (HRS)

          -  Subject is geographically stable to be available for follow up at an approved registry
             center during the whole registry duration

          -  Subject is age 18 or above, or of legal age to give informed consent specific to state
             and national law

        Exclusion Criteria:

          -  Existing contraindications for a BSC ImageReady system as mentioned in the applicable
             reference guides of the implanted system components including a known or suspected
             sensitivity to dexamethasone acetate (DXA)

          -  Implanted pacing system is not ImageReady, i.e. any system components other than BSC
             INGEVITY MRI Conditional leads (or their market released successors), BSC INGENIO MRI
             family pacemaker models and their accessories (or their market released successors)
             intended to have MR Conditional status, including pre-existing abandoned leads of any
             kind still implanted and which will not be removed during the implant or re-implant
             procedure or plugged lead ports

          -  Any existing conditions per local standard of care preventing the subject from
             undergoing an MRI procedure including implanted active or inactive medical devices /
             material, not considered MR Conditional

          -  Subject is enrolled in any other concurrent study with the exception of local
             mandatory governmental registries and studies/registries that are not in conflict and
             do not affect the following:

               1. GENTLE registry outcome (i.e. involve different implantable system components
                  than required for participation in GENTLE or would affect ability to undergo MRI
                  procedures);

               2. Conduct of the GENTLE Registry per Good Clinical Practice (GCP)/ ISO
                  (International Organization of Harmonization) 14155:2011/ local regulations as
                  applicable

          -  Subject is a woman of childbearing potential who is, or might be, pregnant at the time
             of registry enrollment or plans to become pregnant during the course of the registry
             (based on physician's assessment)

          -  Estimated life expectancy of less than twelve months per physician discretion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Gras, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nouvelles Cliniques Nantaises Cardiologie / Médecins du pôle - Unité de Soins et de Cardiologie Interventionnelle 4 rue Eric Tabarly 44277 Nantes cedex 2 France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizinische Universitat Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AKh - Allgemeines Krankenhaus der Stadt Linz GmbH</name>
      <address>
        <city>Linz</city>
        <zip>4021</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziekenhaus Oost Limburg</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grand Hopital De Charleroi</name>
      <address>
        <city>Gilly</city>
        <zip>6060</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jessa Hospital</name>
      <address>
        <city>Hasselt</city>
        <zip>3500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCL de Mont Godinne</name>
      <address>
        <city>Yvoir</city>
        <zip>5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Rhone Durance</name>
      <address>
        <city>Avignon</city>
        <zip>84000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Prive Saint Martin</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Contentin</name>
      <address>
        <city>Cherbourg</city>
        <zip>50100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Marne La Vallee</name>
      <address>
        <city>Jossigny</city>
        <zip>77600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Saint Philibert</name>
      <address>
        <city>Lomme</city>
        <zip>59462</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Prive Jacques Cartier</name>
      <address>
        <city>Massy</city>
        <zip>91300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Les Fontaines</name>
      <address>
        <city>Melun</city>
        <zip>77000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Moulins</name>
      <address>
        <city>Moulins</city>
        <zip>3000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Le Confluent - Nouvelles Cliniques Nantaises</name>
      <address>
        <city>Nantes</city>
        <zip>44277</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Regional Orleans La Source</name>
      <address>
        <city>Orleans</city>
        <zip>45000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupement Hospitalier Pitie Salpetriere</name>
      <address>
        <city>Paris 13</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Saintonge</name>
      <address>
        <city>Saintes Cedex</city>
        <zip>17108</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Gatien</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Bretagne Atlantique</name>
      <address>
        <city>Vannes</city>
        <zip>56017</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite, Universitatsmedizin Berlin, Campus Benjamin Franklin, Klinik fur Kardiologie und Pulmologie</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unfallkrankenhaus Berlin, Klinik fur Innere Medizin</name>
      <address>
        <city>Berlin</city>
        <zip>12687</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Immanuel Klinikum Bernau/Herzzentrum Brandenburg</name>
      <address>
        <city>Bernau</city>
        <zip>16321</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Dusseldorf, Klinik fur Kardiovaskulare Chrirurgie</name>
      <address>
        <city>Dusseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardioangiologisches Centre Bethanien</name>
      <address>
        <city>Frankfurt</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefäßzentrum am Krankenhaus Neu-Bethlehem</name>
      <address>
        <city>Goettingen</city>
        <zip>37073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Marienkrankenhaus Siegen</name>
      <address>
        <city>Siegen</city>
        <zip>57072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Galway</name>
      <address>
        <city>Galway</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bon Secours Hospital</name>
      <address>
        <city>Tralee</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione Poliambulanza</name>
      <address>
        <city>Brescia</city>
        <zip>25131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Annunziata</name>
      <address>
        <city>Cosenza</city>
        <zip>87010</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Spaziani Frosinone</name>
      <address>
        <city>Frosinone</city>
        <zip>03100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Guzzardi di Vittoria</name>
      <address>
        <city>Ragusa</city>
        <zip>00932</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Casilino</name>
      <address>
        <city>Roma</city>
        <zip>00169</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda ULSS 9 Treviso</name>
      <address>
        <city>Treviso</city>
        <zip>31100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Borgo Trento</name>
      <address>
        <city>Verona</city>
        <zip>37126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Gyeonggi-Do</city>
        <zip>463707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>02841</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>100744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yonsei University Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Akershus Universitetssykehus HF</name>
      <address>
        <city>Lorenskog</city>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Professor Doutor Fernando Fonseca, EPE</name>
      <address>
        <city>Amadora</city>
        <zip>2720-276</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar do Alto Ave, EPE</name>
      <address>
        <city>Guimaraes</city>
        <zip>4835-044</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHLO, EPE, Hospital S. Francisco Xavier</name>
      <address>
        <city>Lisbon</city>
        <zip>1449-005</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHLN, EPE Hospital de Santa Maria</name>
      <address>
        <city>Lisbon</city>
        <zip>1649-028</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital dos SAMS</name>
      <address>
        <city>Lisbon</city>
        <zip>1849-017</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Leonor</name>
      <address>
        <city>Madrid</city>
        <zip>28031</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramon y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Puerta de Hierro</name>
      <address>
        <city>Majadahonda</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Merida</name>
      <address>
        <city>Merida</city>
        <zip>06800</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Nuestra Senora de Candelaria</name>
      <address>
        <city>Santa Cruz de Tenerife</city>
        <zip>38010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Concha</name>
      <address>
        <city>Zamora</city>
        <zip>49022</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skanes Universitetssjukhus</name>
      <address>
        <city>Lund</city>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Gorans Sjukhus</name>
      <address>
        <city>Stockholm</city>
        <zip>11219</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsspital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morriston Hospital</name>
      <address>
        <city>Swansea</city>
        <zip>SA6 6NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Norway</country>
    <country>Portugal</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Chile</country>
    <country>Costa Rica</country>
  </removed_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>April 11, 2014</study_first_submitted>
  <study_first_submitted_qc>June 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2014</study_first_posted>
  <results_first_submitted>October 16, 2018</results_first_submitted>
  <results_first_submitted_qc>August 12, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 20, 2019</results_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrollment in the study began on 02 April 2014. The enrollment completion for the GENTLE study was communicated to the participating sites on 26 February 2016. However, additional subjects were enrolled after this date and the last subject signed consent on 08 March 2016. The last subject last visit was on 07 June 2016.</recruitment_details>
      <pre_assignment_details>1184 subjects signed the informed consent (IC). 4 subjects signed the IC only after the end of enrollment. 1180 subjects signed IC before the end of enrollment and are considered 'actively enrolled'. 1174 subjects met all eligibility criteria and were thus considered 'consent eligible' and were considered for the baseline.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Pacemaker/Lead Implant</title>
          <description>All enrolled subjects received an ImageReady Magnet Resonant (MR) Conditional Pacing System according to standard-of-care. No study-specific interventions were performed in the registry. The treatment assignment was based on an &quot;all-comers&quot; consecutive basis.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1184"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Actively Enrolled</title>
              <participants_list>
                <participants group_id="P1" count="1180"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Consent Eligible</title>
              <participants_list>
                <participants group_id="P1" count="1174"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1106"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="78"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Device upgrade</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Enrolled after End of Enrollment</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pacemaker/Lead Implant</title>
          <description>All enrolled subjects will receive an ImageReady Magnet Resonant (MR) Conditional Pacing System and the treatment assignment will be based on an &quot;all-comers&quot; consecutive basis.
ImageReady MR Conditional Pacing System Implant: Implant according to standard-of-care.
No study-specific interventions in that registry.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1174"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.8" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="413"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="761"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Portugal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>South Korea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Belgium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ireland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="372"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary Brady Indication</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sinus bradycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sinus node dysfunction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sinus arrest</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chronotropic incompetence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1st degree AV block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2nd degree AV block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="247"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3rd degree AV block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="293"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="192"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Leads Free From Complication</title>
        <description>Lead-related complication-free rate from lead implant through the three month follow-up, based on complications that are related to the INGEVITY Lead.</description>
        <time_frame>91 calendar days post-implant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pacemaker/Lead Implant</title>
            <description>All enrolled subjects successfully implanted with a complete ImageReady™ System.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Leads Free From Complication</title>
          <description>Lead-related complication-free rate from lead implant through the three month follow-up, based on complications that are related to the INGEVITY Lead.</description>
          <units>percentage of leads complication-free</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1174"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.3" lower_limit="96.2" upper_limit="98.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>MRI Procedures Through 12 Months Post-Implant</title>
        <description>The percentage of subjects who underwent an MRI scan through 12 months post-implant.</description>
        <time_frame>365 calendar days post implant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pacemaker/Lead Implant</title>
            <description>All enrolled subjects successfully implanted with a complete ImageReady™ System.</description>
          </group>
        </group_list>
        <measure>
          <title>MRI Procedures Through 12 Months Post-Implant</title>
          <description>The percentage of subjects who underwent an MRI scan through 12 months post-implant.</description>
          <units>Percentage of subjects with MRI Scan</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1174"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Pacemaker/Lead Implant</title>
          <description>All enrolled subjects successfully implanted with a complete ImageReady™ System.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="197" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Hematological</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Thromboembolic Events</sub_title>
                <description>Cerebrovascular accident</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Thromboembolic Events</sub_title>
                <description>Pulmonary embolism</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial Tachyarrhythmias</sub_title>
                <description>Atrial fibrillation</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Atrial Tachyarrhythmias</sub_title>
                <description>Other Supra Ventricular Tachycardia (SVT)</description>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Atrial Tachyarrhythmias</sub_title>
                <description>Atrial flutter</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Related to Ischemia</sub_title>
                <description>Coronary artery disease</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Related to Ischemia</sub_title>
                <description>Myocardial infarction</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Symptoms (Non-Heart Failure Related)</sub_title>
                <description>Chest pain - Ischemic</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Symptoms (Non-Heart Failure Related)</sub_title>
                <description>Other - Subject condition - Cardiovascular</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Related to Heart Failure</sub_title>
                <description>Heart failure symptoms - Unspecified</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Related to Heart Failure</sub_title>
                <description>Dyspnea - Heart failure</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Related to Heart Failure</sub_title>
                <description>Other- Heart failure subject condition - Cardiovascular</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Related to Heart Failure</sub_title>
                <description>Hypertension - Heart failure</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Ventricular Tachyarrythmias</sub_title>
                <description>Ventricular tachycardia</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Ventricular Tachyarrythmias</sub_title>
                <description>Nonsustained ventricular tachycardia</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Ventricular Tachyarrythmias</sub_title>
                <description>Torsades des pointes</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Endocrine</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Gastrointestinal</description>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Integumentary</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Death</description>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Cancer</description>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Other - Subject condition - Non- cardiovascular</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Head, eyes, ears, nose, throat</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Fever</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Abnormal laboratory values</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Adverse reaction - General</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Symptoms (Non-Heart Failure Related)</sub_title>
                <description>Dizziness</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Symptoms (Non-Heart Failure Related)</sub_title>
                <description>Multiple symptoms</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Symptoms (Non-Heart Failure Related)</sub_title>
                <description>Syncope</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Systemic infection</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Other (Unrelated to Procedure/Device)</sub_title>
                <description>Pericarditis - Unrelated to procedure or device</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>PG System - Subject</sub_title>
                <description>Infection (&gt; 30 days post-implant)</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Physical trauma</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Procedure</sub_title>
                <description>Pneumothorax</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Procedure</sub_title>
                <description>Hemothorax</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Procedure</sub_title>
                <description>Other - Lead - Procedure</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Procedure</sub_title>
                <description>Pericardial effusion</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>PG System - Procedure</sub_title>
                <description>Hematoma - Pocket (≤ 30 days post-implant)</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>PG System - Procedure</sub_title>
                <description>Other - PG system - Procedure</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>PG system - Procedure</sub_title>
                <description>Post-surgical pocket hemorrhage</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Musculoskeletal</description>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Neurological</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Vasovagal reaction</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Right Atrium - Brady</sub_title>
                <description>Dislodgment - No reported signs - RA</description>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Atrium - Brady</sub_title>
                <description>Other - Lead</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Atrium - Brady</sub_title>
                <description>Dislodgment - Elevated threshold - RA</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Atrium - Brady</sub_title>
                <description>Elevated threshold - RA</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Atrium - Brady</sub_title>
                <description>Impedance &gt; 2000 ohms - RA</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Atrium - Brady</sub_title>
                <description>Other - Pulse Generator (PG) system</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Ventricle - Brady</sub_title>
                <description>Dislodgment - No reported signs - RV</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Ventricle - Brady</sub_title>
                <description>Myocardial perforation post-implant - RV</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Ventricle - Brady</sub_title>
                <description>Unable to capture - RV</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Ventricle - Brady</sub_title>
                <description>Conductor coil fracture - RV</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Ventricle - Brady</sub_title>
                <description>Dislodgment - Multiple signs - RV</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Ventricle - Brady</sub_title>
                <description>Dislodgment - Unable to capture - RV</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Right Ventricle - Brady</sub_title>
                <description>Elevated threshold - RV</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Device Deficiency</sub_title>
                <description>Device Deficiency</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Atrial Tachyarrhythmias</sub_title>
                <description>Other SVT (e.g. AVRT, AVNRT, EAT)</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>PG System - Therapy</sub_title>
                <description>Pacemaker-mediated tachycardia</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Psychological</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Genitourinary</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Renal</description>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Cardiovascular/General</sub_title>
                <description>Pulmonary</description>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Symptoms (Non-Heart Failure Related)</sub_title>
                <description>Chest pain - Other</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Symptoms (Non-Heart Failure Related)</sub_title>
                <description>Dyspnea</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Related to Blood Pressure</sub_title>
                <description>Hypertension</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Related to Blood Pressure</sub_title>
                <description>Cardiogenic shock</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Related to Blood Pressure</sub_title>
                <description>Hypotension</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1174"/>
              </event>
              <event>
                <sub_title>Related to Vasculature</sub_title>
                <description>Peripheral vascular disease</description>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1174"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Consultant (PI) acknowledges and agrees that (i) Consultant shall not publish any data, report, white papers or other materials arising out of the Services performed pursuant to this Agreement without the prior written consent of Boston Scientific, and (ii) any such publication shall not include Boston Scientific Confidential Information except prior written consent of Boston Scientific.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dipl.-Ing. (FH) Jens Goetzke</name_or_title>
      <organization>Boston Scientific</organization>
      <phone>+49171 ext 5426813</phone>
      <email>jens.goetzke@bsci.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

